Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173

Blood Cells, Molecules, and Diseases

Volumn 26, Issue 3, 2000, Pages 193-204

  Fajkusová, Lenka ^a,b   Fajkus, Jiří ^c,d   Poláčková, Klára ^c   Fulneček, Jaroslav ^d   Dvořáková, Dana ^a   Krahulcová, Eva ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b Research Institute of Child Health Brno   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Bcr abl locus; CML; CpG island; De novo methylation

Indexed keywords

BCR ABL PROTEIN; BISULFITE; CYTOSINE DERIVATIVE; ENDONUCLEASE; PROTEIN TYROSINE KINASE; URACIL DERIVATIVE;

ALLELE; ARTICLE; CHROMOSOME 22; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033822638     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2000.0296     Document Type: Article

References (26)

1. A minute chromosome in human chronic granulocytic leukemia
2. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
3. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
4. Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment
5. Pathophysiology of CML: Do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone?
6. Evidence for a multistep pathogenesis of chronic myelogenous leukemia
7. Chronic myelogenous leukemia: Recent advances
8. Terminal-phase chronic myelogenous leukemia: Approaches to treatment
9. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia
10. Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia
11. Methylation of the ab11 promoter in chronic myelogenous leukemia: Lack of prognostic significance
12. High sensitivity mapping of methylated cytosines
13. Establishment of a Phl-positive human cell line (BV173)
14. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
15. Mapping of 5-methylcytosine residues in Nicotiana tabacum 5S rRNA genes by genomic sequencing
16. CpNpG methylation in mammalian cells
17. Spl binding is inhibited by (m)Cp(m)CpG methylation
18. Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562
19. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562
20. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization
21. DNA methylation affects the formation of active chromatin
22. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines
23. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein
24. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA
25. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
26. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription